Solarvest Granted EU Patent for Algae Expression System
(firmenpresse) - MONTAGUE, PRINCE EDWARD ISLAND -- (Marketwired) -- 12/18/14 -- SOLARVEST BIOENERGY INC. (TSX VENTURE: SVS) ("Solarvest"), announces that the European patent office has allowed the claims of Solarvest''s "System, Method and Device for the Expression or Repression of Proteins" patent application and will grant the patent. The patent office in Korea has issued a similar approval.
These approvals are a significant milestone in Solarvest''s patent portfolio because this patent covers many areas of bioactive production (expression) in algae. The substantial scope of products covered includes proteins, antigens, and antibiotic like molecules as well as the Company''s clean hydrogen production technology and will provide the patent protection for future research & development programs.
This strengthens Solarvest''s existing patent portfolio and will enable Solarvest to operate unimpeded in several markets including numerous products targeted for human and animal health. This patent is particularly important because it relates to manipulation of cell processes in Algae and consequently improves Solarvest''s position with respect to the use of our unique algae strains as a ''manufacturing platform'' to produce a diverse range of products ranging from vaccines and bioactive proteins to enzymes.
The Company continues to focus on launching its line of organic Omega-3 products.
About Solarvest:
Solarvest is an algae technology company that owns numerous key patents and whose algal-based production platform provides it with an extremely flexible production system. The Company''s wholly owned subsidiary, Solarvest PEI, has developed a patented (pending) process to produce the world''s first organic Omega-3 using algae, to help meet the 13 billion dollar global Omega-3 market. The Solarvest system utilizes a natural process growing the algae under closely controlled conditions ensuring that the health product(s) produced have none of the environmental contaminants found in our oceans. Organic certification provides assurance that the product(s) is GMO free, sustainable, produced without chemicals and, being algae, supports vegetarian and vegan diets. Solarvest''s licensed Organic Omega-3 products will offer the consumer a healthy and sustainable product choice.
The TSX Venture Exchange has neither approved nor disapproved the contents of this news release.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
The statements made in this news release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from Solarvest''s expectations and projections.
Contacts:
Solarvest BioEnergy Inc.
Gerri Greenham
Chief Executive Officer
416 420 0947
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 18.12.2014 - 07:30 Uhr
Sprache: Deutsch
News-ID 1326204
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
MONTAGUE, PRINCE EDWARD ISLAND
Phone:
Kategorie:
Alternative Energy
Anmerkungen:
Diese Pressemitteilung wurde bisher 60 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Solarvest Granted EU Patent for Algae Expression System
"
steht unter der journalistisch-redaktionellen Verantwortung von
Solarvest BioEnergy Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
